Hyperbaric Oxygen Therapy (HBOT): How It Works, What It Treats, and What the Evidence Shows

Hyperbaric oxygen therapy (HBOT) is one of the oldest regenerative treatments still in active clinical use – and one of the few that carries genuine FDA clearance for over a dozen conditions. The core idea is elegantly simple: place a person inside a sealed, pressurized chamber, raise the atmospheric pressure to 1.5-3 atmospheres absolute (ATA), and have them breathe 100% oxygen for 60-90 minutes. The result is a dramatic spike in dissolved oxygen throughout the bloodstream and tissues – reaching areas that compromised blood vessels can no longer supply on their own.

That extra oxygen does far more than just “feed” hungry cells. It triggers a cascade of biological responses: new blood vessel growth (angiogenesis), stem cell mobilization from bone marrow, potent reduction in systemic inflammation, and enhanced antimicrobial activity. These overlapping mechanisms explain why HBOT works for conditions as different as a diabetic foot ulcer and a traumatic brain injury – and why researchers keep finding new applications decades after the therapy was first developed.

But HBOT is also a therapy surrounded by genuine hype. Soft-shell chambers marketed for home use operate at a fraction of the pressure and oxygen concentration used in the clinical research that actually demonstrates benefit. Some clinics promote HBOT for conditions where the evidence simply does not exist yet. In this guide, we separate what is established from what is promising from what is overstated – so you can make a genuinely informed decision about whether hyperbaric oxygen therapy makes sense for your situation.

The Three Core Mechanisms of HBOT

Understanding why HBOT works for such a wide range of conditions requires looking at the three interconnected biological mechanisms it triggers. Each mechanism contributes to healing differently, and for most conditions, all three work together.

How HBOT Works: The Science of Pressurized Oxygen

The physics behind HBOT is governed by two gas laws you may remember from chemistry class. Henry’s Law states that the amount of gas dissolved in a liquid is directly proportional to the pressure of that gas above the liquid. At sea level (1 ATA) breathing room air (21% oxygen), arterial blood carries about 0.3 mL of dissolved oxygen per deciliter. At 3 ATA breathing 100% oxygen, that number jumps to roughly 6.0 mL/dL – a 20-fold increase. Since resting tissue needs about 6 mL/dL to function, HBOT can theoretically sustain tissue oxygenation through dissolved plasma alone, without any hemoglobin contribution at all.

Boyle’s Law explains pressure’s effect on gas volume: as pressure increases, gas bubbles shrink. This is why HBOT is the primary treatment for decompression sickness (the bends) and arterial gas embolism – the elevated pressure physically compresses the nitrogen bubbles causing symptoms. Combined, these two principles create an environment where oxygen saturates tissues at levels impossible under normal conditions.

Chamber Types: Monoplace vs. Multiplace vs. Soft-Shell

Not all hyperbaric chambers are created equal, and the differences matter enormously for clinical outcomes. Here is how the three main types compare:

The 13 FDA-Cleared Indications for HBOT

The Undersea and Hyperbaric Medical Society (UHMS) maintains the list of approved indications that insurance companies and the FDA reference. These are the conditions where evidence is strong enough to warrant formal recognition:

1. Decompression sickness (the bends)
2. Arterial gas embolism
3. Carbon monoxide poisoning
4. Gas gangrene (clostridial myonecrosis)
5. Crush injuries and compartment syndromes
6. Diabetic foot ulcers and problem wounds
7. Exceptional blood loss anemia
8. Intracranial abscess
9. Necrotizing soft tissue infections
10. Refractory osteomyelitis
11. Delayed radiation injury (soft tissue and bone)
12. Compromised skin grafts and flaps
13. Acute thermal burns

For these indications, many insurance plans – including Medicare – cover HBOT when performed in an approved facility. Coverage typically requires documentation of failed conventional treatment and a physician referral.

Evidence by Condition: What the Research Actually Shows

Beyond the FDA-cleared indications, HBOT is being studied and used off-label for a growing number of conditions. Here is an honest assessment of the evidence, graded by quality and quantity of research:

A Deeper Look: HBOT for TBI and Concussion

Traumatic brain injury is arguably the most exciting frontier for HBOT research, and the one where regenerative medicine practitioners see the most dramatic clinical improvements. The rationale is straightforward: after a brain injury, there is often a penumbra of tissue that is alive but metabolically dormant – not dead, but not functioning. These neurons have been “stunned” by the initial trauma and the subsequent neuroinflammation, ischemia, and oxidative stress. HBOT delivers the oxygen needed to “wake up” this dormant tissue.

The most rigorous evidence comes from a series of Israeli trials led by Dr. Shai Efrati and colleagues at the Sagol Center. Their 2013 study randomized chronic TBI patients (1-5 years post-injury) to HBOT or a waitlist control and found significant improvements in cognitive function, headaches, and quality of life – accompanied by measurable changes on SPECT brain imaging showing increased perfusion in previously under-active brain regions. Follow-up studies in 2018 and 2022 have replicated and extended these findings.

US military research has also contributed significantly. The BIMA study and HOPPS trial examined HBOT for service members with persistent post-concussive symptoms, finding symptom improvements though with some controversy over whether the sham control (pressurized air) may itself have been partially therapeutic.

The practical question for TBI patients: the evidence is strongest for chronic TBI (more than 3-6 months post-injury) at pressures of 1.5-2.0 ATA for 40-60 sessions. Acute TBI protocols are still being studied. If you are considering HBOT for a brain injury, look for a facility that performs SPECT or other functional brain imaging before and after treatment to document response.

HBOT for Long COVID

Long COVID may be the condition that brings HBOT into mainstream medical acceptance for neurological applications. The pathophysiology overlaps heavily with what HBOT addresses: microclotting, endothelial damage, neuroinflammation, and tissue hypoxia.

The landmark study is the 2022 randomized, sham-controlled, double-blind trial by Zilberman-Itskovich and colleagues published in Scientific Reports. Seventy-three long COVID patients were randomized to 40 sessions of HBOT at 2.0 ATA or sham treatment. The HBOT group showed significant improvements in cognitive function, energy, sleep, psychiatric symptoms, and pain – and brain MRI demonstrated measurable changes in microstructure and perfusion. This is one of the strongest pieces of evidence for any long COVID intervention to date.

Multiple additional RCTs are underway worldwide, and early results are consistently positive. If you have persistent cognitive dysfunction, fatigue, or exercise intolerance after COVID-19, HBOT is among the most evidence-supported interventions currently available – though it remains off-label and typically not covered by insurance.

What to Expect During an HBOT Session

If you have never been inside a hyperbaric chamber, here is what a typical session looks like:

Before your session: You will change into cotton clothing (no synthetic fabrics, which can generate static). You cannot bring electronics, lighters, or petroleum-based products into the chamber. Your ears will be checked, and you will be taught equalization techniques (similar to what you do on an airplane).

Compression phase (10-15 minutes): The chamber pressure gradually increases. You will feel fullness in your ears and need to equalize frequently. This is the phase most people find uncomfortable initially but quickly adjust to. If you have had ear surgery or have Eustachian tube dysfunction, discuss this with your provider in advance.

Treatment phase (60-90 minutes): Once at target pressure, you simply breathe normally. In a monoplace chamber, the entire atmosphere is 100% oxygen. In a multiplace chamber, you breathe through a hood or mask. Many patients read, watch movies on tablets (some facilities provide these), or sleep. Most people describe a feeling of calm and mild warmth.

Decompression phase (10-15 minutes): Pressure gradually returns to normal. Your ears may pop again. You can resume all normal activities immediately after the session. Some people feel energized; others feel tired. Both responses are normal.

After your session: There is no downtime. Some patients notice increased energy, improved sleep, or temporary lightheadedness. Cumulative benefits typically emerge after 10-20 sessions, with maximum effect often seen at 40 sessions.

Cost, Insurance, and Practical Considerations

For off-label use, the financial commitment is significant. At $250 per session and 40 sessions, you are looking at $10,000 out of pocket. Some patients and clinics report success with less intensive protocols (20-30 sessions), but the bulk of the evidence base uses 40+ sessions. If cost is a barrier, ask about package pricing – many HBOT centers offer 10- or 20-session bundles at reduced per-session rates.

Safety Profile and Side Effects

HBOT has an excellent overall safety profile when administered by trained personnel in properly maintained equipment. However, no medical intervention is without risk. Here is what you need to know:

Hard-Shell vs. Soft-Shell: The Debate

This is perhaps the most contentious topic in the HBOT world, and it deserves a candid discussion. Soft-shell (portable, inflatable) chambers have become enormously popular for home use. They are more affordable, more convenient, and far less intimidating than a clinical hard-shell chamber. But there are important limitations.

Soft-shell chambers are legally limited to 1.3-1.5 ATA and use oxygen concentrators that deliver approximately 24-40% oxygen (compared to 100% in clinical chambers). Running the physics: at 1.3 ATA with 35% oxygen, the dissolved oxygen increase is roughly 2-3 times normal – compared to the 10-15 times increase achieved in a hard-shell chamber at 2.4 ATA with 100% O₂. That is a fundamentally different biological stimulus.

The vast majority of published clinical evidence for HBOT – the studies that demonstrate benefits for TBI, long COVID, wound healing, and other conditions – used pressures of 1.5-3.0 ATA with 100% oxygen. Extrapolating those results to a soft-shell chamber at 1.3 ATA is not scientifically valid. This does not mean soft-shell chambers have zero benefit; some patients report subjective improvements, and there is a biologically plausible mechanism for mild benefit. But the evidence gap is significant.

How to Choose an HBOT Provider

The quality of HBOT delivery varies enormously. Here is what to look for:

• Chamber type: Hard-shell, FDA-cleared Class II device capable of at least 2.0 ATA with 100% oxygen delivery.
• Medical director: A physician trained in hyperbaric medicine, ideally board-certified by the American Board of Preventive Medicine (Undersea and Hyperbaric Medicine subspecialty) or equivalent.
• Safety protocols: Written emergency procedures, fire suppression system, trained technicians present during every session.
• Treatment planning: Willingness to discuss your specific condition, explain the evidence level, set realistic expectations, and use a protocol informed by the published literature.
• Outcome tracking: For neurological conditions, providers who offer pre/post SPECT imaging, neurocognitive testing, or other objective outcome measures are preferable to those who rely solely on subjective reports.
• Transparency about limitations: Be cautious of providers who claim HBOT “cures” everything or who dismiss questions about evidence levels. The best practitioners are candid about what is established versus what is promising.

HBOT in the Context of Regenerative Medicine

HBOT is rarely used in isolation in regenerative medicine practice. It is increasingly integrated as part of multimodal treatment plans that address multiple pathways simultaneously. Common combinations include:

• HBOT + peptide therapy: BPC-157 and TB-500 promote tissue repair through complementary growth factor pathways. Combined with HBOT’s angiogenic and anti-inflammatory effects, some practitioners report enhanced healing outcomes.
• HBOT + IV NAD+: For neurological applications, NAD+ infusions support mitochondrial function while HBOT provides the oxygen substrate those mitochondria need to generate ATP.
• HBOT + platelet-rich plasma (PRP): For musculoskeletal injuries, PRP provides concentrated growth factors while HBOT creates the oxygen-rich environment needed for them to function optimally.
• HBOT + low-dose naltrexone (LDN): For autoimmune and inflammatory conditions, LDN modulates the immune system while HBOT addresses the tissue-level consequences of chronic inflammation.

The logic behind these combinations is sound: HBOT creates the oxygen-rich environment that other regenerative therapies need to work optimally. A wound bed flooded with growth factors (from PRP) but starved of oxygen will not heal as quickly as one that has both. The research on specific combinations is still early, but the physiological rationale is strong.

Frequently Asked Questions

How quickly does HBOT work?

For emergency indications (decompression sickness, carbon monoxide poisoning), benefits are often immediate. For chronic conditions, most patients begin noticing subjective improvements between sessions 10 and 20. Maximum therapeutic benefit typically occurs at 40 sessions, which is why most research protocols use this as the standard course length. Some patients continue to improve for weeks after completing treatment as the angiogenesis and tissue remodeling processes continue.

Is HBOT safe during pregnancy?

HBOT is generally avoided during pregnancy unless the benefit clearly outweighs the risk (such as carbon monoxide poisoning). The effects of hyperbaric oxygen on fetal development have not been adequately studied in humans. If you are pregnant or planning to become pregnant, discuss this with your HBOT provider and obstetrician.

Can I do HBOT at home with a soft-shell chamber?

You can, but understand the significant limitations. Home soft-shell chambers operate at 1.3-1.5 ATA with oxygen concentrators (not 100% oxygen), delivering a fraction of the biological stimulus of clinical HBOT. For serious medical conditions, clinical hard-shell treatment is strongly preferred. Some patients use home chambers for maintenance after completing a clinical course. If you go this route, work with a knowledgeable provider who can guide your protocol and monitor for adverse effects.

How does HBOT compare to ozone therapy?

Both HBOT and ozone therapy use oxygen-based interventions, but they work through different mechanisms. HBOT increases dissolved oxygen directly. Ozone therapy (O₃) works by creating a controlled oxidative stress that upregulates the body’s antioxidant systems. The evidence base for HBOT is substantially larger and more rigorous. Some practitioners combine both modalities, though comparative studies are lacking.

What about HBOT for anti-aging?

The 2020 Hadanny study showing telomere lengthening and senescent cell reduction after 60 HBOT sessions generated significant media coverage. These are legitimate biomarker changes published in a peer-reviewed journal. However, we do not yet know whether these biomarker changes translate into meaningful health outcomes or lifespan extension. The study was small, and independent replication is needed. It is promising but very early – do not spend $15,000+ on HBOT purely for longevity based on a single study.

Can children receive HBOT?

Yes, children can safely receive HBOT for appropriate indications. Pediatric protocols are well-established for conditions like carbon monoxide poisoning and problem wounds. For off-label uses (such as cerebral palsy or autism), the evidence is mixed and parents should carefully evaluate the research before committing to treatment. Children may need additional support with ear equalization. Many facilities allow a parent to accompany the child in a multiplace chamber.

Does HBOT help with sports recovery and performance?

Professional athletes have used HBOT for decades to accelerate recovery from injuries, and there is reasonable evidence that it speeds healing of muscle injuries, fractures, and ligament damage. For general sports recovery (reducing soreness after training), the evidence is weaker and the cost-benefit ratio is questionable. If you are an elite athlete recovering from a specific injury, HBOT may be worth exploring. For general fitness recovery, the evidence does not support the expense.

What should I do if I cannot equalize my ears during a session?

Tell your technician immediately. The chamber operator will slow or halt the pressurization. Techniques include the Valsalva maneuver (pinching your nose and gently blowing), swallowing, yawning, or using the Frenzel maneuver. If you consistently cannot equalize, your provider may recommend a decongestant before sessions or, in rare cases, tympanostomy tubes. Never try to “push through” ear pain – this can cause tympanic membrane rupture.

How do I know if HBOT is working for me?

Objective outcome tracking is ideal. For neurological conditions, pre- and post-treatment SPECT imaging, neuropsychological testing, or standardized symptom questionnaires provide measurable data. For wound healing, wound measurements and photographs document progress. For general symptoms (fatigue, pain, brain fog), keeping a daily symptom journal with 1-10 ratings allows you to track trends that might not be obvious session to session. If you see no improvement after 20 sessions, discuss with your provider whether to continue, modify the protocol, or explore other options.

The Bottom Line

Hyperbaric oxygen therapy is a legitimate, science-backed medical treatment with clear evidence for its FDA-cleared indications and growing evidence for conditions like TBI, long COVID, and stroke recovery. It is not a cure-all, and it is not cheap. But for the right patient with the right condition, treated at the right pressure and for the right number of sessions, HBOT can produce meaningful improvements that conventional medicine alone cannot match.

The key is approaching it with clear eyes: understand the evidence level for your specific condition, choose a qualified provider with proper equipment, and track your outcomes objectively. Do not fall for soft-shell hype or clinics that promise miracles. Do consider HBOT seriously if you have a condition in the “established” or “promising” categories above and have not found adequate relief with conventional approaches.

Related Reading

• Long COVID Treatment: Emerging Therapies and Evidence
• TBI Treatment: Conventional and Regenerative Approaches
• Peptide Therapy: A in-depth Guide
• NAD+ Therapy: Mechanisms, Benefits, and Evidence
• Ozone Therapy: What the Evidence Shows